Categories Earnings, Health Care

AbbVie (ABBV) Q4 earnings preview: Generic competition might weigh on results

With only a few weeks left for closing the high-value acquisition of Allergan, AbbVie (NYSE: ABBV) is busy doing the groundwork for the integration. The company will be unveiling its December-quarter results Friday before the opening bell.

AbbVie (NYSE: ABBV) Q3 2019 Earnings Review

It is widely expected that earnings will rise 6% year-over-year to $2.19 per share, which falls at the upper end of the management’s guidance range. The bottom-line exceeded estimates in three of the trailing four quarters and the positive trend is likely to continue. The consensus estimate for December-quarter revenue is $8.7 billion, which represents a 5% increase.

Humira Slowdown

Of late, AbbVie’s sales have been negatively impacted by generic competition to its flagship product Humira, especially in the overseas market. However, the drug’s relatively stable demand in the U.S. will likely support top-line growth in the to-be-reported quarter.

Related: AbbVie Q3 2019 Earnings Conference Call Transcript

Mavyret, AbbVie’s HCV drugs that registered weak sales most of last year due to competition, might not contribute much to the results. Another factor that affects sales is unfavorable pricing.

Product Mix

On the positive side, the oncology segment has witnessed stable sales growth in the past, mainly for Imbruvica and Venclexta, which will likely continue this time. Also, initial estimates indicate that the company’s plaque-psoriasis drug Skyrizi and arthritis therapy Rinvoq have been doing well since their launch. Since these products are crucial for driving future growth, the market will be keeping a tab on their fourth-quarter performance.

Looking Back

In the third quarter, revenues moved up to $8.5 billion as weakness in the core Immunology segment was more than offset by a strong performance by the Hematologic Oncology unit. Consequently, adjusted earnings increased 9% annually to $2.33 per share and topped expectations.

The company this week said it achieved positive results from an advanced-stage clinical trial on Rinvoq for the treatment of psoriatic arthritis. The drug reportedly met both the primary and secondary endpoints of the study. It is expected to offset the impact of the ongoing slowdown in the sales of Humira.

Also see: Merck & Co. Q4 earnings beat estimates; revenue misses

After underperforming the market for most of 2019, AbbVie shares entered 2020 on a low note. The stock slipped to a three-month low last month but has been regaining strength since then.

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips

Most Popular

IPO Alert: Here’s what to look for when CaliberCos goes public

The massive slowdown in the IPO market continued in the second half as the challenges posed by high inflation and interest rate hikes weighed on investor confidence. Meanwhile, there is

CarMax (KMX) Stock: Does the current dip offer a buying opportunity?

The automotive sector is one of the worst affected by the combination of high inflation and rising interest rates. Consumers have become more cautious and are prioritizing their purchases with

Ultimax Digital gears up for $10mln IPO. Here’s all you need to know

The IPO market has witnessed muted activity this year, and things don’t seem to have improved in the second half. The upcoming public listing of video game technology firm Ultimax

Comments

  1. Pingback: ไฮโล
  2. Pingback: Heavy
  3. Pingback: Heavy R
  4. Pingback: ThopTV APK
  5. Pingback: ff tool
  6. Pingback: ff tools hack
  7. Pingback: clearance
  8. Pingback: bauck
  9. Pingback: FFH4X APK
  10. Pingback: Epaviste gratuit
  11. Pingback: Epaviste
  12. Pingback: enlevement epave
  13. Pingback: Epaviste
  14. Pingback: Epaviste
  15. Pingback: Epaviste gratuit
  16. Pingback: enlevement epave
  17. Pingback: épave automobile
  18. Pingback: Epaviste
  19. Pingback: Epaviste gratuit
  20. Pingback: enlevement epave
  21. Pingback: Epaviste
  22. Pingback: Epaviste
  23. Pingback: enlevement epave
  24. Pingback: épave automobile
  25. Pingback: เว็บ123
  26. Pingback: คาสิโน
  27. Pingback: thc edibles
  28. Pingback: ps5 on sale
  29. Pingback: Epaviste gratuit
  30. Pingback: pink runtz
  31. Pingback: CZ P10C FOR SALE
  32. Pingback: Glock 43x for Sale
  33. Pingback: energy
  34. Pingback: krayzie bone syrup
  35. Pingback: curepod battery
  36. Pingback: Buy This Domain
  37. Pingback: fishscale cocaine
  38. Pingback: classic books
  39. Pingback: Miami models
  40. Pingback: Cute Wallpapers
  41. Pingback: delta 8 juul pods
  42. Pingback: raw gardens carts
  43. Pingback: Island Whisky
  44. Pingback: Buy This Domain
  45. Pingback: slot
  46. Pingback: Best HP Laptops
  47. Pingback: IRA investment
  48. Pingback: poster 1988
  49. Pingback: vintage posters
  50. Pingback: russkaya reklama
  51. Pingback: slayer sneakers
  52. Pingback: w320axgf-9-bxr3-r2
  53. Pingback: Wood tile floor
  54. Pingback: lowes tiles
  55. Pingback: backsplash tile
  56. Pingback: Buy Crack Online
  57. Pingback: Buy MDMA Online
  58. Pingback: esthetic pro
  59. Pingback: esthetician tools
  60. Pingback: ipl machine
  61. Pingback: gadgets
  62. Pingback: entertainment news
  63. Pingback: political news
  64. Pingback: World news
  65. Pingback: Trending videos
  66. Pingback: disclaimer
  67. Pingback: visit homepage
  68. Pingback: find more info
  69. Pingback: this contact form
  70. Pingback: browse this site
  71. Pingback: زواج
  72. Pingback: 9mm Ammo
  73. Pingback: Colt 1911 for Sale
  74. Pingback: Firearms Site
  75. Pingback: Glock 17 for Sale
  76. Pingback: SpytoStyle.Com
  77. Pingback: spytostyle.com
  78. Pingback: SpyToStyle
  79. Pingback: spytostyle.com
  80. Pingback: SpytoStyle.Com
  81. Pingback: spytostyle.com
  82. Pingback: SpyToStyle
  83. Pingback: soi cau 247
  84. Pingback: emupedia
  85. Pingback: lmhmod
  86. Pingback: so em xui la gi
  87. Pingback: tải game bài
  88. Pingback: yacht rental miami

Comments are closed.

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top